Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Cooper

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
British Journal of Cancer|July 3, 2008
DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinomaT J Seng, N Currey, W A Cooper, et al.
The Annals of Thoracic Surgery|October 13, 1998
Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategiesJ P Gott, W A Cooper, F E Schmidt, et al.
Asia-Pacific Journal of Clinical Oncology|August 11, 2017
Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian contextM Itchins, P L Chia, S A Hayes, et al.
Oncogene|June 6, 2017
The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancerA Szczepny, S Rogers, W S N Jayasekara, et al.
Oncogene|April 4, 2017
Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancerR Shakya, G A Tarulli, L Sheng, et al.
British Journal of Cancer|June 12, 2014
Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanomaM S Carlino, L E Haydu, H Kakavand, et al.
Journal of Clinical Pathology|June 13, 2013
EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinomaW A Cooper, B Yu, P Y Yip, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
British Journal of Cancer|July 3, 2008
DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinomaT J Seng, N Currey, W A Cooper, et al.
The Annals of Thoracic Surgery|October 13, 1998
Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategiesJ P Gott, W A Cooper, F E Schmidt, et al.
Asia-Pacific Journal of Clinical Oncology|August 11, 2017
Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian contextM Itchins, P L Chia, S A Hayes, et al.
Oncogene|June 6, 2017
The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancerA Szczepny, S Rogers, W S N Jayasekara, et al.
Oncogene|April 4, 2017
Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancerR Shakya, G A Tarulli, L Sheng, et al.
British Journal of Cancer|June 12, 2014
Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanomaM S Carlino, L E Haydu, H Kakavand, et al.
Journal of Clinical Pathology|June 13, 2013
EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinomaW A Cooper, B Yu, P Y Yip, et al.
Pageof 6